Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells - PubMed (original) (raw)
Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells
E J Shannon et al. Immunopharmacol Immunotoxicol. 1996 Feb.
Abstract
The effect if thalidomide on tumor necrosis factor alpha (TNF-alpha) produced in vitro by lipopolysaccharide (LPS) stimulated human cells was investigated. In cultures of LPS stimulated human mononuclear cells enriched for adherent cells and in cultures of LPS stimulated human monocytes of the cell line-THP-1, thalidomide enhanced the synthesis of TNF-alpha. When cultures of unfractionated peripheral blood mononuclear cells were stimulated with LPS, thalidomide decreased the synthesis of TNF-alpha. Depending on the type of cells stimulated with LPS in vitro, thalidomide, at concentrations achieved in vivo, can either enhance or suppress the synthesis of TNF-alpha.
Similar articles
- Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cells.
Zimecki M, Miedzybrodzki R, Mazurier J, Spik G. Zimecki M, et al. Arch Immunol Ther Exp (Warsz). 1999;47(4):257-64. Arch Immunol Ther Exp (Warsz). 1999. PMID: 10483875 - Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations.
Zwingenberger K, Wnendt S. Zwingenberger K, et al. J Inflamm. 1995-1996;46(4):177-211. J Inflamm. 1995. PMID: 8878794 Review. - Binding to leukocytes and induction of TNF alpha production involve different sites within the lipid-A region of LPS-like molecules.
Mey A, Hmama Z, Normier G, Binz H, Revillard JP. Mey A, et al. Int J Immunopharmacol. 1994 May-Jun;16(5-6):413-7. doi: 10.1016/0192-0561(94)90030-2. Int J Immunopharmacol. 1994. PMID: 7927987 Review.
Cited by
- Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.
Chang X, Zhu Y, Shi C, Stewart AK. Chang X, et al. Acta Biochim Biophys Sin (Shanghai). 2014 Mar;46(3):240-53. doi: 10.1093/abbs/gmt142. Epub 2013 Dec 29. Acta Biochim Biophys Sin (Shanghai). 2014. PMID: 24374776 Free PMC article. Review. - Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice.
Baratz R, Tweedie D, Rubovitch V, Luo W, Yoon JS, Hoffer BJ, Greig NH, Pick CG. Baratz R, et al. J Neurochem. 2011 Sep;118(6):1032-42. doi: 10.1111/j.1471-4159.2011.07377.x. Epub 2011 Aug 5. J Neurochem. 2011. PMID: 21740439 Free PMC article. - A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
Tweedie D, Luo W, Short RG, Brossi A, Holloway HW, Li Y, Yu QS, Greig NH. Tweedie D, et al. J Neurosci Methods. 2009 Oct 15;183(2):182-7. doi: 10.1016/j.jneumeth.2009.06.034. Epub 2009 Jul 5. J Neurosci Methods. 2009. PMID: 19583982 Free PMC article. - The continuing challenges of leprosy.
Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. Scollard DM, et al. Clin Microbiol Rev. 2006 Apr;19(2):338-81. doi: 10.1128/CMR.19.2.338-381.2006. Clin Microbiol Rev. 2006. PMID: 16614253 Free PMC article. Review. - Effects of thalidomide on intracellular Mycobacterium leprae in normal and activated macrophages.
Tadesse A, Shannon EJ. Tadesse A, et al. Clin Diagn Lab Immunol. 2005 Jan;12(1):130-4. doi: 10.1128/CDLI.12.1.130-134.2005. Clin Diagn Lab Immunol. 2005. PMID: 15642997 Free PMC article.